Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro.
about
Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer.Anticancer activity of an extract from needles and twigs of Taxus cuspidata and its synergistic effect as a cocktail with 5-fluorouracilThe efficacy and toxicity of paclitaxel plus S-1 compared with paclitaxel plus 5-FU for advanced gastric cancer: a PRISMA systematic review and meta-analysis of randomized controlled trials.Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel.A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancerInhalable, large porous PLGA microparticles loaded with paclitaxel: preparation, in vitro and in vivo characterization.Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells.Administration sequence-dependent antitumor effects of paclitaxel and 5-fluorouracil in the human gastric cancer cell line MKN45.A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer.S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects.Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer.Schedule-dependent combined sensitivity testing of anti-cancer agents in human gastric carcinoma cell lines.2-Methoxyestradiol-induced caspase-3 activation and apoptosis occurs through G(2)/M arrest dependent and independent pathways in gastric carcinoma cells.A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.Increased antitumor activity in combined treatment TS-1 and docetaxel. A preclinical study using gastric cancer xenografts.Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC).DeepSynergy: Predicting anti-cancer drug synergy with Deep Learning.The Impact of Treatment Preferences in Second-Line Chemotherapy on the Prognosis of HER2-Negative Metastatic Breast Cancer.A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.
P2860
Q24813485-6F029660-CAB9-4512-A3EA-F3078271CAE7Q33381016-370032D0-6FF0-4804-B196-683213BC98ABQ34088371-730D13F4-CBA1-44FC-AF19-93ADAE22AA77Q36193781-678A309B-234E-4D77-A777-756AF8B0E6F8Q36612612-3DA241DC-7ED3-405D-98A4-BDCF0ACCAB92Q36614734-B483DFDC-8B1A-4F9F-BF30-807B60CEB1BFQ36619759-E1CF9E13-628C-4AE3-8D28-DF266A68C75AQ36642170-B0CF2E3C-9595-48EA-95D3-789FC3EBC6E3Q38831758-ECFC4559-3304-4850-A0A6-CD395376D688Q39102243-B81A86B1-B405-4D18-B565-94C43B46B1DCQ39874436-B508F0DA-73D3-481D-915E-C4AF3E692CB0Q40390070-06F2DB31-C852-4C97-8EA8-0C847FCB9BA5Q40498631-6B74CB72-AC81-4119-AA49-D74E4CB49624Q40585342-E9B3A644-5A53-4C82-A2E2-349C4F1EBE2AQ42915841-ECC8F53C-11BA-4583-9B42-E5C1FAF99244Q43686890-323E0F3E-35C7-4718-BDB6-0FF331291B33Q43707350-E600D5BC-5C88-492A-A182-9F2F6293F400Q43792357-D6740824-50D5-4157-AEF5-8416A804525FQ44180988-5CCF3E95-E745-41B3-AB12-35212E93A7B3Q46572791-7D4BD3C3-8DBE-4F26-8227-7201EEF00B6BQ46592422-C823FF04-4A60-41FA-970E-78702F78CC54Q46683166-E578BFAA-A069-4773-9021-C00DDB3400BCQ46822414-F7F3A81C-86F0-48CC-952C-A07156F9703BQ46965901-4190C12E-095F-4C36-821F-5778ADD41212Q47290651-0B215D55-B658-4D24-B403-A268FC700C47Q50347388-A7615F51-B69A-4CB5-9C98-4438CB91B444Q52682114-4933FA14-B65F-411C-8F45-5D8989764860
P2860
Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Schedule-dependent interaction ...... carcinoma cell lines in vitro.
@ast
Schedule-dependent interaction ...... carcinoma cell lines in vitro.
@en
type
label
Schedule-dependent interaction ...... carcinoma cell lines in vitro.
@ast
Schedule-dependent interaction ...... carcinoma cell lines in vitro.
@en
prefLabel
Schedule-dependent interaction ...... carcinoma cell lines in vitro.
@ast
Schedule-dependent interaction ...... carcinoma cell lines in vitro.
@en
P2093
P2860
P356
P1476
Schedule-dependent interaction ...... carcinoma cell lines in vitro.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.425
P407
P577
1996-09-01T00:00:00Z
P5875
P6179
1044638087